Literature DB >> 30690756

Response to 'Sex-by-formulation interaction in bioequivalence studies: the importance of formulations and experimental conditions' by Ibarra et al.

Esperanza González-Rojano1, Francisco Abad-Santos1, John Gordon2, Alfredo García-Arieta3.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 30690756      PMCID： PMC6422725          DOI： 10.1111/bcp.13860

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  3 in total

1.  Sex-by-formulation interaction in bioequivalence studies: the importance of formulations and experimental conditions.

Authors:  Manuel Ibarra; Marta Vázquez; Pietro Fagiolino
Journal:  Br J Clin Pharmacol       Date:  2019-01-02       Impact factor: 4.335

2.  Evaluation of sex-by-formulation interaction in bioequivalence studies of efavirenz tablets.

Authors:  Esperanza González-Rojano; Francisco Abad-Santos; Dolores Ochoa; Manuel Román; Julio Marcotegui; Covadonga Álvarez; John Gordon; Alfredo García-Arieta
Journal:  Br J Clin Pharmacol       Date:  2018-05-22       Impact factor: 4.335

3.  Sex-by-formulation interaction assessed through a bioequivalence study of efavirenz tablets.

Authors:  Manuel Ibarra; Laura Magallanes; Marianela Lorier; Marta Vázquez; Pietro Fagiolino
Journal:  Eur J Pharm Sci       Date:  2016-02-03       Impact factor: 4.384
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.